These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28914078)

  • 1. Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Elf J; Svensson PJ; Strandberg K; Sundquist J; Memon AA
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):416-422. PubMed ID: 28914078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.
    Memon AA; Sundquist J; Zöller B; Wang X; Dahlbäck B; Svensson PJ; Sundquist K
    Thromb Res; 2014 Mar; 133(3):322-6. PubMed ID: 24359967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Svensson PJ; Sundquist J; Memon AA
    Thromb Haemost; 2016 Aug; 116(3):432-41. PubMed ID: 27277397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein M in patients with chronic kidney disease.
    Sørensen IM; Bertelsen M; Freese E; Lindhard K; Ullum H; Feldt-Rasmussen B; Nielsen LB; Christoffersen C; Bro S
    Atherosclerosis; 2018 Aug; 275():304-311. PubMed ID: 29980057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.
    He L; Wu P; Tan L; Le B; Du W; Shen T; Wu J; Xiang Z; Hu M
    Lipids Health Dis; 2017 Sep; 16(1):167. PubMed ID: 28877724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein M and Risk of Type 2 Diabetes.
    Hajny S; Christoffersen M; Dalila N; Nielsen LB; Tybjærg-Hansen A; Christoffersen C
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32621749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable Isotope Kinetic Study of ApoM (Apolipoprotein M).
    Croyal M; Billon-Crossouard S; Goulitquer S; Aguesse A; León L; Fall F; Chétiveaux M; Moyon T; Blanchard V; Ouguerram K; Lambert G; Nobécourt E; Krempf M
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):255-261. PubMed ID: 29146748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum high-density lipoprotein correlates with serum apolipoprotein M and A5 in obstructive sleep apnea hypopnea syndrome.
    Tan S; Liu X; Xu Y; Luo L; Zhou S; Gao Y
    Sleep Breath; 2017 Mar; 21(1):37-44. PubMed ID: 27206623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Apolipoprotein M and Inflammatory Factors in Obese Patients.
    Li T; Yang L; Zhao S; Zhang S
    Med Sci Monit; 2018 Aug; 24():5698-5703. PubMed ID: 30110274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
    Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
    Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein N-linked homocysteine is associated with recurrence of venous thromboembolism.
    Szlauer A; Mielimonka A; Głowacki R; Borowczyk K; Stachniuk J; Undas A
    Thromb Res; 2015 Nov; 136(5):911-6. PubMed ID: 26371408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
    Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K
    Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.
    Ahmad A; Memon AA; Sundquist J; Svensson PJ; Zöller B; Sundquist K
    Gene; 2018 Mar; 647():136-142. PubMed ID: 29325734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence.
    Kunutsor SK; Seidu S; Blom AW; Khunti K; Laukkanen JA
    Eur J Epidemiol; 2017 Aug; 32(8):657-667. PubMed ID: 28718029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein M Serum Levels Correlate with IgA Vasculitis and IgA Vasculitis Nephritis.
    Wu J; He L; Bai L; Tan L; Hu M
    Dis Markers; 2019; 2019():1825849. PubMed ID: 31885732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism].
    Liu FF; Zhai ZG; Yang YH; Wang J; Wang C
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1860-3. PubMed ID: 24124734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein.
    Kunutsor SK; Seidu S; Katechia DT; Laukkanen JA
    Ann Med; 2018 May; 50(3):240-248. PubMed ID: 29448840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function.
    Kovářová M; Koller T; Štvrtinová V; Payer J
    Endokrynol Pol; 2015; 66(6):474-9. PubMed ID: 26662645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.